Arun Anaesthesia Academy

Child-Pugh Score Calculator

Arun Anaesthesia Academy Clinical Severity Score
i

Child-Pugh Score — About

The Child-Pugh score grades severity of chronic liver disease using 5 parameters (3 biochemical, 2 clinical), each scored 1–3 points. Total range 5–15. Used for prognosis, surgical risk stratification, and to guide drug-dose adjustments in hepatic impairment.

Select an option for each of the five parameters below. The score, class and prognosis update live.

1

Total Bilirubin

— pts
Enter a measured value or select a band Units:
μmol/L
Enter a value to auto-score, or pick a band below.
2

Serum Albumin

— pts
Enter a measured value or select a band Units:
g/L
Enter a value to auto-score, or pick a band below.
3

INR (or PT prolongation)

— pts
Enter the INR or select a band PT seconds prolonged shown for reference
INR
Enter a value to auto-score, or pick a band below.
4

Ascites

— pts
Clinical assessment From examination / imaging / response to therapy
5

Hepatic Encephalopathy

— pts
West Haven grading Including effect of any current treatment

Total Score & Class

Total Child-Pugh Score
/ 15
Awaiting input
Select all five parameters to see the final score, class and prognosis.
Class A
Score 5 – 6  ·  Well-compensated
1-yr survival: ~100%
2-yr survival: ~85%
Operative mortality (abd): ~10%
Class B
Score 7 – 9  ·  Significant compromise
1-yr survival: ~80%
2-yr survival: ~60%
Operative mortality (abd): ~30%
Class C
Score 10 – 15  ·  Decompensated
1-yr survival: ~45%
2-yr survival: ~35%
Operative mortality (abd): ~70 – 80%
Anaesthetic implications: Class A patients tolerate most procedures with standard precautions. Class B requires careful preoperative optimisation and avoidance of hepatotoxic drugs. Class C carries very high perioperative mortality — elective surgery is generally contra-indicated; only life-saving procedures should be undertaken, ideally at a transplant centre.
⚠️ Clinical Disclaimer: Score is a guide only. Bilirubin thresholds differ in primary cholestatic disease (PBC/PSC: 1 pt <68, 2 pts 68–170, 3 pts >170 μmol/L). Always interpret in clinical context, alongside MELD score and assessment of frailty/comorbidity. The developer accepts no liability for clinical decisions made using this tool.